2021’s medtech M&A ticks up further

Vantage Data Points

The two small deals this week – Neogenomics buying the oncology IT group Trapelo Health for $65m and Seaspine’s $110m move on the robotic surgical navigation specialist 7D Surgical – bring the total spent so far this year on medical technology M&A to $15.8bn. 23 deals with disclosed value have been announced since January, though one, the $375m tie-up between Hillrom and Bardy Diagnostics, is currently on the rocks.

 

Related Topics

Share This Article